IEEE Rev Biomed Eng. 2018;11:260-274. doi: 10.1109/RBME.2018.2826984. Epub 2018 Apr 16.
Droplet microfluidics utilizes two immiscible flows to generate small droplets with the diameter of a few to a few hundred micrometers. These droplets are promising tools for biomedical engineering because of the high throughput and the ease to finely tune the microenvironments. In addition to the great success of droplet biomicrofluidics in the proof-of-concept biosensing, regenerative medicine, and drug delivery, few droplet biomicrofluidic devices have a transformative impact on the industrial and clinical applications. The main issues are the low volume throughput and the lack of proper methods for quality control and automation. This review covers the methodologies for the mass production, detection, and automation of droplet generators. Recent advances in droplet mass production using parallelized devices and modified junction structures are discussed. Detection techniques, including optical and electrical detection methods, are comprehensively reviewed in detail. Newly emerged droplet closed-loop control systems are surveyed to highlight the progress in system integration and automation. Overall, with the advances in parallel droplet generation, highly sensitive detection, and robust closed-loop regulation, it is anticipated that the productivity and reliability of droplet biomicrofluidics will be significantly improved to meet the industrial and clinical needs.
液滴微流控利用两种不混溶的流体制备直径为数微米到数百微米的微小液滴。由于高通量和易于微调微环境,这些液滴是生物医学工程的有前途的工具。除了液滴生物微流控在概念验证生物传感、再生医学和药物输送方面取得了巨大成功外,很少有液滴生物微流控设备对工业和临床应用产生变革性影响。主要问题是体积通量低,缺乏适当的质量控制和自动化方法。本综述涵盖了用于大规模生产、检测和自动化的液滴发生器的方法。讨论了使用并行化设备和改进的连接结构进行液滴大规模生产的最新进展。详细全面地综述了检测技术,包括光学和电气检测方法。调查了新出现的液滴闭环控制系统,以突出系统集成和自动化方面的进展。总的来说,随着并行液滴生成、高灵敏度检测和稳健的闭环调节的进步,可以预期液滴生物微流控的生产率和可靠性将得到显著提高,以满足工业和临床需求。